Literature DB >> 8606261

Potential mechanisms promoting restenosis in diabetic patients.

D Aronson1, Z Bloomgarden, E J Rayfield.   

Abstract

Diabetes is associated with greater restenosis rates after successful balloon angioplasty. The metabolic alterations that occur as a result of hyperglycemia or hyperinsulinemia can accelerate many of the pathophysiologic processes that lead to restenosis. Diabetes results in endothelial dysfunction and accelerated platelet deposition, which increase the propensity to thrombosis. Several growth factors known to promote the restenosis process are overexpressed in the presence of hyperglycemia. Advanced glycosylation promotes inflammatory cell recruitment and smooth muscle cell proliferation. Many of the potential mechanisms promoting restenosis in diabetic patients can be ameliorated by improved metabolic control.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8606261     DOI: 10.1016/0735-1097(95)00496-3

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  40 in total

1.  Is surgery still the preferred option for coronary revascularisation in diabetics with multivessel coronary disease?

Authors:  A Kapur; I S Malik
Journal:  Heart       Date:  2002-05       Impact factor: 5.994

Review 2.  Percutaneous coronary intervention in diabetics.

Authors:  Juhana Karha; Deepak L Bhatt
Journal:  Rev Endocr Metab Disord       Date:  2004-08       Impact factor: 6.514

3.  Are complex coronary lesions more frequent in patients with diabetes mellitus?

Authors:  Nezihi Baris; Bahri Akdeniz; Samet Uyar; Erdem Ozel; Onder Kirimli; Ozer Badak; Ozgur Aslan; Sema Guneri
Journal:  Can J Cardiol       Date:  2006-09       Impact factor: 5.223

4.  Darwin and the survival of the fittest in modern interventional cardiology.

Authors:  V K Bhatia; C Di Mario
Journal:  Heart       Date:  2006-01-31       Impact factor: 5.994

5.  Controlled release from multilayer silk biomaterial coatings to modulate vascular cell responses.

Authors:  Xianyan Wang; Xiaohui Zhang; John Castellot; Ira Herman; Mark Iafrati; David L Kaplan
Journal:  Biomaterials       Date:  2007-11-28       Impact factor: 12.479

6.  Long-term benefits of internal thoracic artery-coronary artery bypass in Japanese patients.

Authors:  S Kitamura; K Kawachi; S Taniguchi; T Kawata; S Kobayashi; H Nishioka; K Mizuguchi; K Niwaya; Y Kameda; H Sakaguchi
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  1998-01

Review 7.  Optimal treatment for coronary artery disease in patients with diabetes: percutaneous coronary intervention, coronary artery bypass graft, and medications.

Authors:  Hiroshi Ito
Journal:  Gen Thorac Cardiovasc Surg       Date:  2011-01-12

Review 8.  Coronary artery disease and diabetes mellitus.

Authors:  Doron Aronson; Elazer R Edelman
Journal:  Cardiol Clin       Date:  2014-06-10       Impact factor: 2.213

Review 9.  Percutaneous versus surgical interventions for coronary artery disease in those with diabetes mellitus.

Authors:  Ozlem Soran
Journal:  Curr Cardiol Rep       Date:  2013-01       Impact factor: 2.931

10.  Association of elevated fasting glucose with lower patency and increased major adverse limb events among patients with diabetes undergoing infrapopliteal balloon angioplasty.

Authors:  Satinder Singh; Ehrin J Armstrong; Walid Sherif; Bejan Alvandi; Gregory G Westin; Gagan D Singh; Ezra A Amsterdam; John R Laird
Journal:  Vasc Med       Date:  2014-06-17       Impact factor: 3.239

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.